Stay updated with breaking news from Diffusion Pharmaceuticals Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, May 20, 2024 -- CervoMed Inc. , a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment of William Elder as Chief...
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, announced an...
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Diffusion Pharmaceuticals stock opened at $4.40 on Friday. The firm has a 50 day moving average price of $4.64 and a […]
/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...
Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $4.40 on Friday. The firm has a 50 day moving average of $4.84 […]